U.S. Industrials Stock News

Several class action lawsuits tied to Boston Scientific (BSX) have followed its weaker than expected fourth quarter and full year 2025 results and softer 2026 guidance, putting the company’s U.S. Electrophysiology disclosures under close investor scrutiny. See our latest analysis for Boston Scientific. At a share price of $69.13, Boston Scientific has had a challenging spell, with a 90 day share price return showing a 25.01% decline and a year to date share price return showing a 27.01%...

Recent performance snapshot EMCOR Group (EME) has drawn fresh attention after a mixed short term performance, with the stock roughly flat over the past week, a decline over the past month, and a gain over the past 3 months. See our latest analysis for EMCOR Group. At a share price of US$709.91, EMCOR Group’s recent pullback, including an 11.35% 1 month share price return decline, comes after a strong run that leaves its year to date share price return at 11.16% and its 1 year total...

American Express (NYSE:AXP) has launched new long term partnerships with major sports venues and teams in the New York/New Jersey and Atlanta markets. The company becomes the official payments partner for high profile venues including MetLife Stadium and Mercedes Benz Stadium. Eligible card members are set to receive exclusive access, presale ticket opportunities, and on site perks tied to these collaborations. For investors watching NYSE:AXP, these partnerships come at a time when the...

Paycom Software (NYSE:PAYC) has launched a new Career and Succession Planning tool for its HR platform. The tool is designed to automate successor identification, assess bench strength and provide real time analytics for talent decisions. This product update focuses on helping clients manage long term leadership pipelines within a single system. For investors watching NYSE:PAYC, this product launch comes as the stock trades around $125.71 and has experienced a 39.1% decline over the past...

If you are looking at NIKE and wondering whether the recent share price reflects its true worth, you are not alone. This article is built to help you frame that question clearly. The stock closed at US$53.98, with returns of a 5.3% decline over 7 days, 14.5% decline over 30 days, 14.7% decline year to date, 22.8% decline over 1 year, 52.5% decline over 3 years and 57.6% decline over 5 years. These figures may change how investors think about both risk and potential opportunity. Recent...

Quantum Computing Inc. (NasdaqCM:QUBT) and Ciena carried out a joint demonstration of quantum secure communication solutions at OFC 2026. The demo combined quantum key distribution, quantum authentication, and post quantum cryptography in real world network conditions. The event focused on how quantum era security tools could be applied to commercial grade telecom and data network infrastructure. The collaboration highlighted the potential for quantum secure systems to address emerging...

Why JPMorgan Chase Stock Is Back in Focus JPMorgan Chase (JPM) has moved to mark down several software linked private credit loans and tighten lending to that sector, a risk management shift that has rattled parts of the broader financial market. See our latest analysis for JPMorgan Chase. That tighter stance on private credit comes after JPMorgan Chase's share price has seen a 12.92% decline year to date and an 11.43% 90 day share price retreat, even as its 1 year total shareholder return of...

Celanese Corporation recently reported that Timothy Go resigned from its Board of Directors on February 27, 2026, with the company clarifying that his departure was not due to any disagreement over operations, policies, or practices. At the same time, analysts have highlighted Celanese’s ability to push through price increases and potentially widen margins amid tighter global supply chains and geopolitical disruptions, reshaping how investors view its earnings power under stressed market...

Integer Holdings Corporation recently entered a cooperation agreement with activist investor Irenic Capital Management, appointing James F. Flanagan and Aaron Kapito to its expanded 13-member Board and assigning them to key committees, alongside standstill, voting, and non-disparagement commitments through at least early 2027. This governance reset brings deep financial, operational, and activist-investor experience directly into Integer’s boardroom at a time when shareholder fiduciary-duty...

U.S. policymakers abruptly withdrew a planned global licensing rule on AI chip exports that would have affected Advanced Micro Devices (NasdaqGS:AMD) and its peers. The reversal removes a major regulatory overhang on international sales of AMD’s advanced AI accelerators. This policy shift broadens the potential global market for AMD’s AI products at a time when the company is focused on AI infrastructure demand worldwide. For you as an investor, this matters because AMD is heavily exposed...

What Has Been Happening With RBC Bearings Stock RBC Bearings (RBC) has attracted fresh attention after a recent pullback, with the share price showing a 2% decline over the past week and almost 3% over the past month. That short term softness comes alongside a past 3 months total return of about 16% and a 1 year total return close to 59%. This has prompted some investors to reassess how the current level around $536 compares with the company’s fundamentals. See our latest analysis for RBC...

Why Vishay Intertechnology (VSH) Is On Investors’ Radar Today Vishay Intertechnology (VSH) is drawing attention after recent share price moves that include a gain over the past 3 months alongside a month pullback, putting its current US$17.23 price in focus. See our latest analysis for Vishay Intertechnology. That recent 3 month share price return of 13.73% sits alongside a 30 day share price pullback of 8.74% and a more modest 1 year total shareholder return of 4.82%. Together, these figures...

First look at Sarepta Therapeutics after recent share price moves Sarepta Therapeutics (SRPT) has been on many investors’ screens after a series of sharp share price moves, including a 3.8% decline in the latest session and a loss of more than 23% in the past 3 months. See our latest analysis for Sarepta Therapeutics. At a share price of $16.40, Sarepta Therapeutics has seen a 1 day share price return of 3.76% decline and a 90 day share price return of 23.9% decline. The 1 year total...

McCormick (MKC) has been in focus after a recent analyst downgrade to strong sell. The move pulled the stock lower and sharpened attention on its 2026 outlook for margins, tariffs, and commodity costs. See our latest analysis for McCormick. Beyond this downgrade, McCormick’s latest share price of $58.29 comes after a 1 month share price return of 18.46% decline and a 1 year total shareholder return of 25.54% decline, suggesting sentiment has weakened even as it launches new products like the...

Nextpower (NXT) has been in focus after GLJ Research initiated coverage with a positive view on its vertically integrated solar tracker offering, along with the company’s new agrivoltaics solution targeting Italian developers. See our latest analysis for Nextpower. Those positives have arrived alongside strong price momentum, with the 1-day share price return of 3.23% and 7-day share price return of 17.95% sitting on top of a 90-day share price return of 37.26% and a 1-year total shareholder...

Vicor stock moves after strong multi period returns Vicor (VICR) has drawn fresh attention after a sharp move in its share price, with the stock showing gains over the past week, month, past 3 months and on a 1 year and multi year basis. See our latest analysis for Vicor. At the current share price of $172.57, Vicor’s recent 90 day share price return of 80.53% and 1 year total shareholder return of 221.60% point to strong momentum that has built over time rather than a short term spike. If...

Earlier this month, nLIGHT, Inc. showcased its new 70kW-class Laser Weapon System and recently released 30kW and 10kW high-energy lasers at the Pacific Operational Science & Technology Conference in Honolulu, highlighting its vertically integrated approach to defense-grade laser manufacturing. At the same time, CEO Scott H. Keeney’s US$1.1 million stock sale under a Rule 10b5-1 plan has drawn attention to how insider transactions sit alongside strong recent growth in aerospace, defense, and...

If you are wondering whether Avista's current share price lines up with its underlying value, this article will walk through what the key numbers are really saying. Over the past week Avista has a 0.5% return, compared with a 7.5% decline over the last 30 days and returns of 3.0% year to date and 4.9% over 1 year, with a 3 year return of 11.7% and 5 year return of 8.8% that can help frame how the current US$39.87 share price fits into its recent history. Recent price moves have come against...

Recent analyst upgrades have pushed Verizon Communications (VZ) into the spotlight, with firms highlighting its postpaid subscriber momentum, cost reduction efforts, and consistent dividend growth as key drivers of growing investor interest. See our latest analysis for Verizon Communications. The recent analyst upgrades and Verizon’s focus on cost cuts and subscriber growth sit alongside a strong share price run, with a 30 day share price return of 4.84% and a 90 day share price return of...

In recent days, Clean Harbors reported record free cash flow in 2025, continued multi-year margin expansion in its Environmental Services segment, and announced plans for US$250,000,000 in share buybacks alongside refreshed analyst coverage signaling confidence in its operations. The news also underscores how growing demand for PFAS remediation and services linked to reshoring manufacturing is increasingly central to Clean Harbors’ role in the environmental services ecosystem. We’ll now...

Eli Lilly (LLY) is back in focus after outlining a US$3b, decade-long investment in China tied to its oral GLP-1 drug orforglipron, while separately pressing U.S. regulators on compounded tirzepatide safety. See our latest analysis for Eli Lilly. Despite a series of obesity drug launches, access initiatives, legal headlines and this new US$3b China plan, Eli Lilly’s short term share price performance has cooled. The company has seen a 30 day share price decline of 5.28% and a year to date...

Eastman Chemical (EMN) is back in focus after management expanded its 2026 self help plan, pairing higher targeted cost reductions with an emphasis on cash generation and capital returns that analysts have recently highlighted. See our latest analysis for Eastman Chemical. At a share price of US$69.25, Eastman Chemical has a 30 day share price return of 13.52% decline but a 90 day share price return of 8.29% gain. The 1 year total shareholder return of 20.23% loss and 5 year total shareholder...

Earlier this month, TPG Inc. filed a US$282.34 million shelf registration for 6,383,349 Class A shares tied to its employee stock ownership plan, while the firm also contended with sector-wide stress after JPMorgan Chase moved to restrict lending to private credit providers and TPG limited redemptions on key funds. At the same time, TPG’s climate platform completed a complex exit from Intersect to Google, reshaping its exposure to fast-growing data center and clean power infrastructure...

In recent days, CG Oncology drew attention as multiple research firms updated their views on the company, while it expanded its at-the-market stock offering to up to US$550 million to support progress toward a Biologics License Application for its bladder cancer therapy candidate, cretostimogene. Analysts pointed to recent clinical and market validation in intermediate-risk non-muscle invasive bladder cancer and CG Oncology’s advancing PIVOT-006 trial as important factors shaping how...